24小时热门版块排行榜    

Znn3bq.jpeg
查看: 1703  |  回复: 10
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

PSA

专家顾问 (著名写手)

[交流] NDA for tasocitinib to treat RA 已有5人参与

Pfizer Inc. (NYSEFE), New York, N.Y.
Product: Tofacitinib (CP-690,550) (formerly tasocitinib)
Business: Autoimmune
Molecular target: Janus kinase-3 (JAK-3); Janus kinase-1 (JAK-1)
Description: Oral pan-Janus kinase (JAK) inhibitor
An NDA for tofacitinib to treat rheumatoid arthritis (RA) is
under FDA review with an Aug. 21 PDUFA date, while an MAA is
under review in the EU. The product is also under review in Japan.
In a conference call to discuss its 2Q12 earnings, Pfizer said FDA
requested additional analysis of data in the NDA for tofacitinib,
which the pharma said could cause the agency to extend its review
of the product past its PDUFA date. Specifics about the request
were not disclosed (see BioCentury, Aug. 6). Tofacitinib also is in
Phase III testing to treat moderate to severe plaque psoriasis.
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) has
rights from Pfizer to co-market tofacitinib in Japan for RA and other
undisclosed indications
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

药道人

荣誉版主 (文坛精英)

净由秽生,明从闇出

优秀版主优秀版主


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
6楼: Originally posted by PSA at 2012-08-20 15:29:08
你不看好tofacitinib上市?还是不看好合作开发呵呵!...

Tofacitinib片剂,具有口服给药的优势,但tofacitinib并未证明比抗肿瘤坏死因子药物更加有效,而且其长期安全性仍然是一个谜。例如,与tofacitinib有关的胆固醇及肝酶水平升高的风险是否易于纠正,抑或该风险是否预示着服用该药的患者,在未来面临着心脏问题及严重的器官损坏。且市场已经饱和。
虽然是新靶点,但药效超不过现有药物,你拿什么跟人家竞争?
来时胡涂去时迷,空在人间走这回。未曾生我谁是我,生我之后我是谁?长大成人方知我,合眼朦胧又是谁?不如不来也不去,亦无烦恼亦无悲。
7楼2012-08-20 15:39:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 11 个回答

cpujacs

荣誉版主 (知名作家)

优秀版主优秀版主优秀版主



小木虫: 金币+0.5, 给个红包,谢谢回帖
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) has rights from Pfizer to co-market tofacitinib in Japan for RA and other undisclosed indications
这种合作是不是将来的一种趋势
3楼2012-08-20 13:15:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

PSA

专家顾问 (著名写手)

合作开发,挺好的呵呵!
4楼2012-08-20 13:22:26
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

PSA

专家顾问 (著名写手)

引用回帖:
5楼: Originally posted by 药道人 at 2012-08-20 14:29:39
不看好

你不看好tofacitinib上市?还是不看好合作开发呵呵!
6楼2012-08-20 15:29:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 材料与化工调剂 10+7 下一站上岸@ 2026-04-10 17/850 2026-04-10 11:52 by 来看流星雨10
[考研] 生物与医药调剂 +5 十七sa 2026-04-05 5/250 2026-04-10 08:14 by kangsm
[考研] 314求调剂 +16 xhhdjdjsjks 2026-04-09 17/850 2026-04-09 18:26 by 喝醉酒N
[考研] 337求调剂 +4 Gky09300550, 2026-04-09 4/200 2026-04-09 17:18 by 帕尔马拉特
[考研] 一志愿电子科技大学085600材料与化工 329分求调剂 +14 Naiko 2026-04-04 14/700 2026-04-09 16:56 by luoyongfeng
[考研] 一志愿085404,总分291,四级已过,求调剂 +10 阿俊阿俊阿俊 2026-04-04 12/600 2026-04-09 16:18 by lin-da
[考研] 085400电子信息类(川大控制工程)求调剂可跨专业 求老师联系 +3 626776879 2026-04-08 3/150 2026-04-09 16:05 by 猪会飞
[考研] 349学科化学045106求调剂,化学类都可以 +8 保好懂懂 2026-04-08 8/400 2026-04-09 14:03 by xulei3024
[考研] 265求调剂 +4 风说她早忘了 2026-04-07 4/200 2026-04-09 13:59 by only周
[考研] 材料专硕322 +14 哈哈哈吼吼吼哈 2026-04-05 14/700 2026-04-09 13:25 by 5268321
[考研] 二次调剂求老师收留 +3 笑笑袁 2026-04-08 3/150 2026-04-08 23:50 by 醉在风里
[考研] 318求调剂 +13 ykyhsa 2026-04-05 15/750 2026-04-08 21:37 by wj165256
[考研] 307求调剂 +14 超级伊昂大王 2026-04-06 14/700 2026-04-08 07:03 by 无际的草原
[考研] 材料工程专业日语生求调剂 +9 111623 2026-04-07 9/450 2026-04-07 23:31 by 一只好果子?
[考研] 机械调剂 +3 zzzbcb 2026-04-07 3/150 2026-04-07 22:19 by hemengdong
[考研] 085404 293求调剂 +8 勇远库爱314 2026-04-06 9/450 2026-04-07 13:05 by flydream1314
[考研] 材料与化工363求推荐 +11 zh096 2026-04-04 11/550 2026-04-06 19:14 by guanxin1001
[考研] 283求调剂 +5 baiiyu 2026-04-05 6/300 2026-04-05 20:35 by 啵啵啵0119
[考研] 085600调剂 +9 东照照照 2026-04-04 9/450 2026-04-05 13:44 by ujn_zhuj
[考研] 268求调剂 +8 你好tg 2026-04-03 9/450 2026-04-04 05:08 by gswylq
信息提示
请填处理意见